How to cite item

Is there a safe time to stop clopidogrel in patients on dual antiplatelet therapy after a percutaneous coronary intervention and placement of drug-eluting stents?

  
@article{JTD17278,
	author = {Nureddin Almaddah and Rami N. Khouzam},
	title = {Is there a safe time to stop clopidogrel in patients on dual  antiplatelet therapy after a percutaneous coronary intervention  and placement of drug-eluting stents?},
	journal = {Journal of Thoracic Disease},
	volume = {9},
	number = {12},
	year = {2017},
	keywords = {},
	abstract = {No clear evidence determines the most effective duration for dual antiplatelet therapy (DAPT) after drug-eluting stents (DES). Although DES reduces the rate of restenosis compared with bare-metal stents (BMS), it is of concern that they may be associated with a risk of stent thrombosis beyond 1 year post treatment. Many randomized clinical trials demonstrated the effectiveness of DAPT in preventing stent thrombosis; a serious complication of PCI. Additionally, it is believed that DAPT prevents adverse occurrences consequent to plaque rupture at a location other than the stented one. Such are the results of a study that compared medical treatment of acute coronary syndrome with Aspirin versus DAPT with clear reduction in the rate of myocardial infarction (MI) in patients who received DAPT (1).},
	issn = {2077-6624},	url = {http://jtd.amegroups.com/article/view/17278}
}